
Septerna, Inc.
Septerna, Inc. (SEPN)
WebsitePrice
Market cap
Next catalystExpected Q1 2027SEP-479 — Phase 1 SAD/MAD in healthy adults · Phase 1 dataSEC filing ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved